Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03996811
Other study ID # 2019-06-003A
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 24, 2019
Est. completion date July 31, 2023

Study information

Verified date March 2021
Source Taipei Veterans General Hospital, Taiwan
Contact Hui-Mei Chen, PhD
Phone 886-939654302
Email alice@ntunhs.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate the effectiveness of a rehabilitation program in improving physical functioning, cardiovascular health index, negative emotions, and quality of life in patients with hemodialysis in Taiwan. Hypothesis: 1. The quality of life in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, and 24th month. 2. The negative emotions in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, and 24th month. 3. The cardiovascular health index in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, and 24th month. 4. The Physical Functioning in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, and 24th month.


Description:

This study will investigate the effectiveness of a rehabilitation program in improving Physical Functioning, cardiovascular health index, negative emotions, and quality of life in patients with hemodialysis in Taiwan.


Recruitment information / eligibility

Status Recruiting
Enrollment 104
Est. completion date July 31, 2023
Est. primary completion date July 31, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: -Patients with hemodialysis who were aged =20 years, could communicate in either Mandarin or Taiwanese, 6-minute walking test ? 300m and not cognitively impaired were included. Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise education
weekly telephone consultations concerning exercise. we discussed whether participants' exercise fulfilled the prescribed intensity, duration, or frequency and whether the participants experienced any adverse effects.

Locations

Country Name City State
Taiwan National Taipei University of Nursing and Health Sciences Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Veterans General Hospital, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary subjective quality of life using Kidney Disease Quality of Life Questionnaire-36™ (KDQOL-36™) to measure quality of life. 3rd month after recruited
Primary subjective quality of life using Kidney Disease Quality of Life Questionnaire-36™ (KDQOL-36™) to measure quality of life. 6rd month after recruited
Primary subjective quality of life using Kidney Disease Quality of Life Questionnaire-36™ (KDQOL-36™) to measure quality of life. 12rd month after recruited
Primary subjective quality of life using Kidney Disease Quality of Life Questionnaire-36™ (KDQOL-36™) to measure quality of life. 24rd month after recruited
Secondary subjective negative emotions negative emotions including anxiety and depression (Hospital Anxiety and Depression Scale). The Hospital Anxiety and Depression Scale include anxiety and depression subscales, a total of 7 questions, each subscale is a four-point scoring method, 0 point for "not at all", 3 points for "always do", each subscale scores is between 0 and 21, that a score of 7 or less for non-cases, scores of 8-10 for doubtful cases and scores of 11 or more for definite cases. 3rd month after recruited
Secondary subjective negative emotions negative emotions including anxiety and depression (Hospital Anxiety and Depression Scale). The Hospital Anxiety and Depression Scale include anxiety and depression subscales, a total of 7 questions, each subscale is a four-point scoring method, 0 point for "not at all", 3 points for "always do", each subscale scores is between 0 and 21, that a score of 7 or less for non-cases, scores of 8-10 for doubtful cases and scores of 11 or more for definite cases. 6rd month after recruited
Secondary subjective negative emotions negative emotions including anxiety and depression (Hospital Anxiety and Depression Scale). The Hospital Anxiety and Depression Scale include anxiety and depression subscales, a total of 7 questions, each subscale is a four-point scoring method, 0 point for "not at all", 3 points for "always do", each subscale scores is between 0 and 21, that a score of 7 or less for non-cases, scores of 8-10 for doubtful cases and scores of 11 or more for definite cases. 12rd month after recruited
Secondary subjective negative emotions negative emotions including anxiety and depression (Hospital Anxiety and Depression Scale). The Hospital Anxiety and Depression Scale include anxiety and depression subscales, a total of 7 questions, each subscale is a four-point scoring method, 0 point for "not at all", 3 points for "always do", each subscale scores is between 0 and 21, that a score of 7 or less for non-cases, scores of 8-10 for doubtful cases and scores of 11 or more for definite cases. 24rd month after recruited
Secondary objective cardiovascular health index serum 3rd month after recruited
Secondary objective cardiovascular health index serum 6rd month after recruited
Secondary objective cardiovascular health index serum 12rd month after recruited
Secondary objective cardiovascular health index serum 24rd month after recruited
Secondary check Physical Functioning 6MWT(Six Minute Walk Test) 3rd month after recruited
Secondary check Physical Functioning 6MWT(Six Minute Walk Test) 6rd month after recruited
Secondary check Physical Functioning 6MWT(Six Minute Walk Test) 12rd month after recruited
Secondary check Physical Functioning 6MWT(Six Minute Walk Test) 24rd month after recruited
See also
  Status Clinical Trial Phase
Recruiting NCT04892745 - Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance
Not yet recruiting NCT04925674 - Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. Phase 1
Active, not recruiting NCT03183245 - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Phase 3
Completed NCT03365635 - Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C Phase 4
Withdrawn NCT02904343 - Evaluation of Domestic Hemodialysis Machine: A Multi-center Clinical Study N/A
Withdrawn NCT01855334 - L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD Phase 4
Completed NCT01700465 - Estimating and Predicting Hemodynamic Changes During Hemodialysis N/A
Recruiting NCT01195519 - The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis N/A
Completed NCT00737672 - GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis Phase 3
Completed NCT00527774 - Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients N/A
Completed NCT00942253 - Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS) Phase 2
Completed NCT00224081 - DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) Phase 4
Completed NCT00850252 - Use of a Lifeline Graft in the A-V Shunt Model Phase 1/Phase 2
Completed NCT00776750 - Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients Phase 4
Recruiting NCT06351007 - Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK) N/A
Withdrawn NCT03664141 - Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) Phase 3
Completed NCT03909698 - Antibiotic Dosing in Patients on Intermittent Hemodialysis
Recruiting NCT03311321 - Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients N/A
Recruiting NCT06098924 - HD Patients' Depression and Happiness
Recruiting NCT03419923 - Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage N/A